Geographical prevalence of KS and seroprevalence of KSHV: a) The age-standardized incidence rate of Kaposi sarcoma (KS) per 100,000 males is depicted, and rates (apart from for the USA) were obtained from the International Agency for Research on Cancer (IARC) Cancer Incidence in Five Continents Volume X1 and ‘Cancer Today’ Global Cancer Observatory resources b) Seroprevalence rates were compiled from multiple studies | Cesarman, E., Damania, B., Krown, S. E., Martin, J., Bower, M., & Whitby, D. (2019). Kaposi sarcoma. Nature Reviews. Disease Primers, 5(1), 9.

Leave a Reply